Outcome After Non-invasive Ventilation.

June 10, 2020 updated by: Jakob Wallden

Outcome After Non-invasive Ventilation - an Observational Study at the Intensive Care Unit at Sundsvall Hospital.

The study is an exploratory retrospective observational study with the aim to describe outcome fo the cohort of patients that receive non-invasive ventilation at an intensive care unit.

Main research questions are:

  • Characteristics of the cohort.
  • The course for the patients at the ICU.
  • ICU-mortality and 30-day mortality
  • Amount of patients with limitations of care.
  • Factors associated with mortality.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • X
      • Sundsvall, X, Sweden, 851 86
        • Västernorrland County Council / Sundsvall Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients admitted to Sundsvalls intensive care unit treated with non-invasive ventilation.

Description

Inclusion Criteria:

  • Patients treated with Non invasive ventilation
  • Admitted to Sundsvalls ICU during 2018

Exclusion Criteria:

  • Below 18 years age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with non-invasive ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient characteristics
Time Frame: At the day of admission to the ICU - 1 day
Age, gender, comorbidities, indications for respiratory support, BMI, limitations of care.
At the day of admission to the ICU - 1 day
ICU-mortality
Time Frame: Patients will be followed during their ICU-stay - estimated to be 1 to 60 days.
Death occuring during ICU stay
Patients will be followed during their ICU-stay - estimated to be 1 to 60 days.
30-day mortality
Time Frame: 30 days from admission to ICU
Death within 30 days after ICU admission
30 days from admission to ICU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors associated with mortality
Time Frame: 30 days from admission to ICU
Evaluate patient and ICU-factors and relation to mortality.
30 days from admission to ICU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Erik Svensk, MD, Västernorrland county council (Region Västernorrland)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

October 2, 2019

First Submitted That Met QC Criteria

October 3, 2019

First Posted (Actual)

October 4, 2019

Study Record Updates

Last Update Posted (Actual)

June 12, 2020

Last Update Submitted That Met QC Criteria

June 10, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • NIV-SUNDSVALL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Insufficiency

3
Subscribe